Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Medical Trial in Patients with Xerostomia

Dec 2nd, 2008
by admin.

LA JOLLA, Calif., Dec. 2 (HSMN NewsFeed) — TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced positive results from a 26 patient Phase II trial evaluating 3 doses of NGX267 as a treatment for xerostomia, or dry mouth, in patients with Sj…
Biopharmaceuticals
TorreyPines Therapeutics, NGX267, xerostomia, Sjogren’s syndrome

Posted in: Medical Sales Jobs.

← Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters
Caroline Loewy Joins Corcept as Chief Financial Officer →

0 Comments on “TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Medical Trial in Patients with Xerostomia”

Leave a Comment